Can you get Addyi in Australia? The short answer, and the one nobody gives you
I want to start with what I actually felt, because I think you might have felt it too.
Around 2015, the headlines started. Female Viagra. The little pink pill. A drug for women who had lost their desire, finally approved, finally taken seriously. My symptoms started at about 39, and I'm 44 now, so I was either right at the beginning of this or about to be, and I had no idea. What I remember isn't the science. It's the tone of the coverage. Triumphant. Slightly smug. As though a door had been opened.
Then nothing. No follow-up here. No GP ever mentioned it. Nothing on a pharmacy shelf.
Years later, while trying to work out what was happening to me, I went looking for it properly.
What I actually wanted from Addyi
Not a sex drive like I was twenty. I want to be clear about that, because it's what people assume you mean and it isn't what a single woman I've spoken to has meant.
What I wanted was the option.
There's a state that's hard to describe to anyone who hasn't been in it. You love your partner. You remember enjoying this. Nothing is wrong, exactly. And then the moment arrives, and there's just nothing there to work with. Not a no. Not a yes. An absence where the wanting used to be.
You want to want to. And you don't.
That's the gap Addyi was built for. Not dryness, not pain, not mechanics. The wanting itself. And I think that's why the headlines landed the way they did on so many of us, because for the first time something was aimed at the part that had actually gone quiet.
If you've never been able to name that state, I've written about it properly in Responsive Desire: What It Is, and Why It's Not Low Libido.
What Addyi actually does, and why it isn't Viagra
This is the part the coverage got wrong, and it's worth understanding before you decide whether you even want it. Viagra works on blood flow. It's plumbing. It does nothing at all to make someone want sex; it just makes the body cooperate once they already do. Addyi was the first drug approved anywhere that went after desire itself, and that is a completely different ambition.
Its real name is flibanserin, and it isn't a hormone. It works on brain chemistry, turning serotonin down slightly and dopamine and noradrenaline up in the part of the brain involved in wanting. If you've read anything I've written about Emily Nagoski's brakes and accelerator model, you'll recognise exactly what that is. Addyi is a pharmaceutical attempt to ease off the brake. I find that fascinating, and I have never once seen it explained that way in an article about the pink pill.
Here's what the headlines left out. It's a daily tablet, taken at bedtime, and the bedtime part isn't a preference. It can drop your blood pressure and make you faint, which is why daytime dosing isn't allowed. You take it every night for around eight weeks before you know whether it's doing anything. And the trial results were modest: roughly one additional satisfying sexual experience every two months compared with placebo.
Which is not nothing, if this is causing you real distress. But it's a long way from a pill you take before dinner.
The line nobody tells you
Now the part that made me put my phone down.
Addyi is approved for premenopausal women. The wording is specific: acquired, generalised low sexual desire in premenopausal women. It was never approved for women past menopause.
AndroFeme, the testosterone cream Australia did approve, is for postmenopausal women.
So the two treatments cover opposite ends of a woman's life. And perimenopause, which is where this change actually begins for most of us and can start in your late thirties, sits in the gap between them.
Neither drug is formally approved for the years when this most commonly starts.
I want to be fair about why, because it isn't purely neglect. The Australasian Menopause Society's guidance on testosterone is honest that the evidence in premenopausal women simply isn't strong enough yet. The trials were done in postmenopausal women, so that's what the approval covers. That's how regulation is supposed to work.
But it does mean that a lot of us are standing in a doorway built for the room before ours and the room after ours, not the one we're in.
So, the short answer
No. Addyi has never been approved by the TGA. It is not on the Australian Register of Therapeutic Goods, your GP cannot write you an ordinary prescription for it, and you will not find it in a pharmacy here. The same goes for Vyleesi, the other desire drug approved in the United States, which is an on-demand injection rather than a daily pill. Australia hasn't approved either of them.
If you keep searching, you'll find overseas sites offering to ship flibanserin to you. I'd think carefully about that. Not to be precious, but because it has real interactions with alcohol, with a long list of common medications, and with anything affecting the liver. Buying it from a site that asks you nothing means taking it with nobody checking it against what you're already on.
Its US approval was contested, went before the FDA more than once, and it still carries a boxed warning about alcohol. That warning was softened in 2019, but it's still there.
What we do have, and almost nobody knows it
Here's the part that never makes the articles.
In November 2020, the TGA approved AndroFeme 1, a testosterone cream for women, for low sexual desire with associated distress in postmenopausal women. It reached pharmacies here in April 2021. Australia was the first regulator in the world to approve a product like it. Not the tenth. The first. So while we don't have the pink pill, we have something the United States still doesn't.
Two honest caveats.
The first is the approval wording, which puts those of us in perimenopause in that familiar grey zone where prescribing happens but sits outside the strict indication. The second is money. It isn't subsidised, so you'll pay somewhere between $107 and $140 for a tube that lasts around three to four months.
That last part has been fought over. In November 2025 the medicines advisory committee declined to recommend it for the PBS, and the manufacturer has taken the decision to the Federal Court. Meanwhile there are eight testosterone products subsidised on the PBS in Australia, and all eight of them are formulated for men.
I'll leave that sitting there without further comment.
What to actually ask for
I'll be honest with you: I haven't had this conversation with my own GP yet. I've been circling it for a while, the way you circle a thing you're not sure you're allowed to ask for. Part of why I'm writing this is to open the conversation, for you and for me at the same time. Here's what I've worked out is worth asking.
Ask about testosterone. Specifically, by name. Most GPs won't raise it themselves, not out of unwillingness but because it sits outside routine practice and there's still very little training in it. Ask whether AndroFeme is appropriate for you, what your baseline levels are, and what they'd want to check first.
Ask for the ordinary things to be ruled out in the same appointment. Thyroid, iron, B12. And have a straight conversation about anything you're already taking, because antidepressants are a very common and very under-discussed cause of exactly this. I've written more about how the hormonal picture fits together in HRT and desire: what I wish someone had told me sooner.
Since July 2025 there's a Medicare item for a menopause health assessment, which buys you a longer appointment than the standard one. More than 100,000 women have used it already. If you've been trying to raise something like this in a rushed fifteen minutes and getting nowhere, that's worth knowing.
And if you want a doctor who is genuinely across this, the Department of Health's find a doctor tool and the Australasian Menopause Society's member directory are the two most useful links I can give you.
One more thing
I know the search that brought you here, because I did it too.
There's something particular about discovering that a treatment exists somewhere else and not for you. It arrives as one more closed door in a run of them, and if you're already feeling like your body has stopped making sense, it confirms something you didn't want confirmed.
But the honest answer isn't that there's nothing. It's that what we have is different from what you went looking for, far less publicised, and in one specific respect ahead of the rest of the world.
And none of it, not the pill we don't have or the cream we do, changes the first thing worth knowing, which is that you are not broken.
You just have to know to ask for it by name.
This article is for general education only and is not medical advice. HRT and other drugs mentioned are medical treatments, and you should make decisions about them with a qualified healthcare provider who understands your history, symptoms, and risk factors.
Martina Baroncelli
Founder of Arousi. Background in pharmaceutical sales and product development. Writing from her own experience of perimenopause.